|
|
|
Volumn 32, Issue 2, 2010, Pages 158-160
|
|
[Diagnosis and treatment of HER-2-positive breast cancer: Expert consensus of the Chinese Anti-Cancer Association].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
MONOCLONAL ANTIBODY;
PACLITAXEL;
TRASTUZUMAB;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
FEMALE;
HUMAN;
METABOLISM;
PATHOLOGY;
TUMOR RECURRENCE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
RECEPTOR, ERBB-2;
|
|
EID: 79955060337
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
